Skip to main content

Table 1 Demographics of the subjects

From: Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

  Subject number (female to male) MDS-OAβ Age
Sex
 Female 98 0.904 ± 0.130 63.1 ± 9.6
 Male 64 0.901 ± 0.134 62.9 ± 8.8
Clinical state
 HNC 92 (53:39) 0.852 ± 0.130 60.5 ± 7.5
 SCD 17(10:7) 0.925 ± 0.111 66.1 ± 9.5
 MCI 15(9:6) 0.964 ± 0.098** 70.0 ± 9.2**
 AD 38(26:12) 0.993 ± 0.089*** 65.1 ± 11.1*
  1. HNC healthy normal control, SCD subjective cognitive decline, MCI mild cognitive impairment; AD Alzheimer’s disease dementia
  2. *p value < 0.05, **p value < 0.01, ***p value < 0.001, a significance of the difference when compared with Healthy Normal Control by ANOVA using R package